19/02/2025 — Interview on YouTube
In a new episode of the Infinita City Podcast, host Niklas Anzinger — founder of Infinita City and investor in Unlimited Bio — spoke with Ivan Morgunov and Dr. Anna Vakhrusheva, co-founders of Unlimited Bio. The conversation explored the intersection of biotech, governance innovation, and longevity entrepreneurship in Próspera ZEDE, Honduras.
Key insights from the discussion:
The episode offered a rare inside look at how startups like Unlimited Bio combine scientific audacity with governance innovation, paving the way for faster translation of gene therapy breakthroughs into real-world applications.
In a new episode of the Infinita City Podcast, host Niklas Anzinger — founder of Infinita City and investor in Unlimited Bio — spoke with Ivan Morgunov and Dr. Anna Vakhrusheva, co-founders of Unlimited Bio. The conversation explored the intersection of biotech, governance innovation, and longevity entrepreneurship in Próspera ZEDE, Honduras.
Key insights from the discussion:
- The Journey of Unlimited Bio. Ivan and Anna shared how they built a biotech company from the ground up in a special economic zone designed for innovation.
- Tackling Aging with Gene Therapy. They discussed the science behind VEGF, Follistatin, Klotho, and BDNF constructs — and the next step: combination “cocktail” therapies for multi-pathway rejuvenation.
- Regulatory Opportunities. The founders explained how Próspera’s regulatory sandbox accelerates preclinical and early-access trials compared to traditional frameworks.
- New Biotech Models. The discussion touched on sovereign biotech hubs, tokenized research, and how decentralized governance can reshape the future of longevity R&D.
The episode offered a rare inside look at how startups like Unlimited Bio combine scientific audacity with governance innovation, paving the way for faster translation of gene therapy breakthroughs into real-world applications.